The CATIE Exchange

The CATIE Exchange - September 20, 2017 

Highlights in this Issue

  • CATIE Forum: Early-bird registration closes on October 13
  • The Public Health Agency of Canada releases a new report on hepatitis B and C
  • CATIE News: Heart attacks earlier among people with HIV; safety of HIV treatment during pregnancy; aging-related issues in older HIV-positive people; treatment guidelines for gonorrhea
  • CanHepC is offering training fellowships in hepatitis C research
  • Hepatitis C workshops for clinicians who work with people who use drugs

2017 CATIE Forum update: How has new HIV treatment and prevention science changed your practice?

The science of risk has changed. Attend the CATIE Forum to learn more about how new HIV treatment and prevention science, and campaigns like Undetectable = Untransmittable, can change the narratives around risk.

The CATIE Forum will take place in Toronto on November 23-24. Register now and save $100! Early-bird registration closes on October 13.

New Resources

FACTSHEET: Asunaprevir (Sunvepra)

CATIE, 2017

Asunaprevir (Sunvepra) is a medication used to treat people with hepatitis C virus. It is taken with daclatasvir (Daklinza). This combination is approved in Canada for people with genotype 1b hepatitis C virus.

Download the PDF

FACTSHEET: Odefsey

CATIE, 2017

This fact sheet provides information on Odefsey, a fixed-dose co-formulation of three anti-HIV drugs: tenofovir alafenamide (TAF), emtricitabine (FTC) and rilpivirine.

Download the PDF

Report on Hepatitis B and C in Canada: 2014

Public Health Agency of Canada (PHAC), 2017

This report summarizes surveillance data on cases and rates of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in Canada, reported from 2005 to 2014.

Download the PDF

News

Ontario researchers call for better awareness of treatment guidelines for gonorrhea

Frailty, nerve injury and falls in middle-aged and older HIV-positive people

Ontario researchers find heart attacks occur earlier in people with HIV

Quebec study is reassuring about the safety of HIV treatment during pregnancy

HCV treatment found safe and effective in individuals with kidney disease

Improved treatment allowing more HIV-positive women to get pregnant: study

HepCinfo Update 8.18: New hepatitis C medications Maviret and Vosevi approved in Canada; Treatment access improving in B.C. with direct-acting antivirals

CATIE updates

The CATIE Blog

The CATIE Blog is our way of bringing more people into the conversation about HIV and hepatitis C. Check out the most recent posts from our contributors:

Highlights from our Partners

Pacific AIDS Network (PAN): New webinars on the overdose response, HIV and aging

PAN is hosting two new webinars this fall in their KnowledgeConnect webinar series:

Register today!

Action Canada for Sexual Health & Rights: Beyond the Basics

Educational modules that teach young people about sexuality and sexual health – from a sex-positive perspective – will be available on September 28, 2017. Leading up to the launch, Action Canada for Sexual Health & Rights would like to hear what you wish you had learned in sex ed. Visit their Facebook page to let them know.

International Network on Hepatitis in Substance Users (INHSU): HCV in Primary Care and Drug and Alcohol Settings education program

This fall, INHSU is holding an educational program across Canada on “HCV in Primary Care and Drug and Alcohol Settings”. Designed by an expert Canadian steering committee, the program will strengthen the capacity of clinical staff to diagnose, treat and manage hepatitis C among people who use drugs. Positions are reserved for clinicians eligible to prescribe hepatitis C medications. Here is the fall lineup:

Click on the links above to register for a workshop. Details for the Edmonton workshop will be announced soon.

Global Health Strategies: Apply for funding

In honour of Universal Health Coverage (UHC) Day (December 12, 2017), Global Health Strategies is offering a limited number of grants to support the events and activities of UHC Coalition members. The deadline for submissions is October 15, 2017.

Canadian Network on Hepatitis C (CanHepC): Available fellowships

CanHepC is pleased to announce that the competition to recruit new trainees is now open. These fellowships provide transdisciplinary training and stipend support to both Canadian and foreign individuals involved in hepatitis C research, who are university graduates at various stages of their academic and professional career. The deadline to submit applications is November 30, 2017. The award guide and application forms are available on their website.

Ontario HIV Treatment Network (OHTN): Indigenous Learning Pathways to Prevention Award

Through this award, the OHTN hopes to engage young people in community-based research to improve the prevention, treatment and care programs offered to their communities around sexually transmitted and blood-borne infections, including HIV. The latest competition will fund two Indigenous students conducting community-based projects with an Indigenous health or community-based agency in Ontario. More details about eligibility are available in the Call for Expressions of Interest.

Realize: Stephen Tattle receives the Elisse Zack Award for Excellence in HIV and Rehabilitation

Realize is pleased to announce that the recipient of the Elisse Zack Award for Excellence in HIV and Rehabilitation is Stephen G. Tattle. To read Stephen’s biography, click this link.

Bright ideas!

Ready for Action: a website that appeals to MSM in Quebec

September 2017

Launched in 2007, COCQ-SIDA’s* bilingual website Ready for Action (or Prêt pour l’action in French) is a resource that offers practical sexual health information to men who have sex with men (MSM). It was created for gay, bisexual and other MSM in Quebec, whether they are cis or trans, francophone or anglophone.

With a visually appealing design and easy navigation, the website provides information on HIV, STBBIs, prevention methods, sexual activities and the risks associated with them, as well as prevention in different relationship contexts. Additionally, built-in tools allow visitors to find testing services located near them by entering their postal code, and can sign up for testing reminders sent by text message or e-mail every three or 12 months depending on their profile settings.

Because HIV and STBBI knowledge evolves rapidly, one of the biggest challenges for the administrators of the site is to ensure that the information is up-to-date. “Scientific breakthroughs and announcements like Undetectable = Untransmittable mean that we have to constantly revise our site and adapt the content so it reflects current realities. And a revision also entails a translation,” explains COCQ-SIDA.

In the last 12 months, an average of almost 2,000 visitors per month have visited the website. COCQ-SIDA attributes the success of the website to three things. First, the site promotes a positive view of sexuality, one that does not judge the sexual activities of MSM. Second, the site is regularly promoted through social marketing campaigns, such as Sex on the Menu. Last, beyond providing sex-positive information, the site uses explicit and accessible language that is easy to understand and appealing to a wide variety of MSM.

Ready for Action will continue to evolve: COCQ-SIDA plans to add a Spanish version of their website and a section about the psychosocial, psychological and emotional needs of MSM.

For more information about Ready for Action, contact René Légaré, Communication Coordinator for COCQ-SIDA: rene.legare@cocqsida.com.

*COCQ-SIDA stands for Coalition des organismes communautaires québécois de lutte contre le sida and is a coalition that encompasses 36 organizational members.